Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A Guide to Mechanical Circulatory SupportMechanical Circulatory Support Indications and Patient Selection

A Guide to Mechanical Circulatory Support: Mechanical Circulatory Support Indications and Patient... [The natural history of advanced heart failure is progressive and eventually terminal. Patients diagnosed with end-stage heart failure exhibiting New York Heart Association (NYHA) Class IV heart failure symptoms and on optimal medical management should be considered for left ventricular assist device therapy (VAD). Escalation of goal-directed medical management, intolerance of neurohormonal antagonists, and increasing diuretic dosing are just a few triggers for referral for VAD therapy considerations. Absolute and relative contraindications are outlined in this chapter and should be collectively considered when determining candidacy for mechanical support therapy. This chapter will detail these important variables to assist the medical team in determining the treatment recommendation for advanced heart failure therapies.] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png

A Guide to Mechanical Circulatory SupportMechanical Circulatory Support Indications and Patient Selection

Editors: Stewart, Scott; Blood, Peggy

Loading next page...
 
/lp/springer-journals/a-guide-to-mechanical-circulatory-support-mechanical-circulatory-LmfUz8JVYF

References (3)

  • JK Kirklin (2020)

    865

    J Thorac Cardiovasc Surg, 159

  • NK Ranganath (2020)

    91

  • LW Miller (2013)

    1209

    J Am Coll Cardiol, 61

Publisher
Springer International Publishing
Copyright
© The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2022
ISBN
978-3-031-05712-0
Pages
29 –37
DOI
10.1007/978-3-031-05713-7_3
Publisher site
See Chapter on Publisher Site

Abstract

[The natural history of advanced heart failure is progressive and eventually terminal. Patients diagnosed with end-stage heart failure exhibiting New York Heart Association (NYHA) Class IV heart failure symptoms and on optimal medical management should be considered for left ventricular assist device therapy (VAD). Escalation of goal-directed medical management, intolerance of neurohormonal antagonists, and increasing diuretic dosing are just a few triggers for referral for VAD therapy considerations. Absolute and relative contraindications are outlined in this chapter and should be collectively considered when determining candidacy for mechanical support therapy. This chapter will detail these important variables to assist the medical team in determining the treatment recommendation for advanced heart failure therapies.]

Published: Nov 9, 2022

Keywords: Left ventricular assist device; Indications; Selection criteria; Advanced heart failure

There are no references for this article.